Outsourcing in Clinical Trials Asia 2021
Virtual Event: 8am CST / 9am KST-JST
29th-30th June, 2021
Download Agenda
Outsourcing in Clinical Trials Asia 2021
Advertisement
The leading clinical Outsourcing conference in Asia is returning on 29th & 30th June 2021. With a focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, this is an event not to be missed.
The 2019 conference was our most successful event to date, across the 2 days, delegates heard from some of the most innovative biopharmaceutical companies and service providers from across Asia and further afield.
In 2021, not only will the audience be discussing clinical partnership and outsourcing challenges, but we also have the Clinical Trial Supply East Asia conference co-located with the event to give you the opportunity to define an end-to-end clinical strategy.
If you are interested in being involved in the 2021 conference, then please register your interest today.
A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES RIGHT AT A TAP OR CLICK OF A BUTTON
Simply register, login on the day and get ready to connect and learn. With the right network at your fingertips, learning and connecting have never been so easy.
💻 Watch live and recorded thought leadership presentations
🗣️ Take part in live Q&A with industry experts from across the globe
👩💻 One-to-one & group video chat with each solution provider
🤝 Chat & network with anyone on the platform
📊 Take part in our interactive polls
👥 Join live panel debates and discussions
🛍️ Download resources from solution providers to your event bag
Why Attend
NETWORK
-
Over the course of 2 days of extensive networking breaks and social sessions, attendees will have the opportunity to make new connections and rediscover old contacts
LEARN
-
Delegates will listen and take part in over 20 learning sessions by leading biopharma from across East Asia. The programme will reflect the best in class case studies of clinical trial excellence leaving attendees inspired for their own studies
ACTION
-
The exhibition will feature 30 globally leading vendors with best in class solutions and ideas to solve your trial challenges and help you seize opportunities

Mainfong Ang
Region Head TMO China,Novartis
Biography:
Session Details: Risk-Based Monitoring & Quality Management 29-06-2021, 1:15 pm View In Agenda

Alan Choi
Vice President,Ildong Pharmaceutical
Biography:
Session Details: Outlining critical criteria to consider when selecting vendor to find the happy medium considering time, quality and cost 29-06-2021, 9:00 am View In Agenda

Jun Park
EVP and Chief Technology Officer,ILIAS Biologics
Biography: Professional Career
- 2020-Present, a member of Global Pharma Key Opinion Leader (GPKOL) for CMC/cGMP, Korea Health Industry Development Institute
- 2020-Present: ILIAS Biologics, Chief Technology Officer, Daejeon, Korea
- 2017-2019: Helixmith, SVP/Head of CMC, Seoul, Korea
- 2006-2017: US FDA/CDER/Office of Biotechnology Products, Maryland, USA
- 1999-2006: US DOD, Edgewood Chemical Biological Center, Maryland, USA
- 1989-1999: Alpha-Beta Technology, Massachusetts, USA
- Worcester Polytechnic Institute, Ph.D., Biochemical Engineering, Massachusetts, USA
- KAIST, MS, Chemical Engineering, Seoul, Korea
- Yonsei University, BS, Chemical Engineering, Seoul, Korea
Session Details: Significant differences in CMO relationships and cooperation between Big pharma and small medium pharmaceutical companies 29-06-2021, 1:15 pm View In Agenda

Sangeun Cho
Analytical research Team Manager/CMC RA,Daewoong Pharmaceutical
Biography:
Session Details: Navigating the Supply Chain Challenges in Cell Therapy product 29-06-2021, 12:15 pm View In Agenda

SinYoung Choi
General Manager,HansBiomed

Jihyun Yoo
Project Manager,SCM lifescience
Biography:
Session Details: Sharing strategies for successful temperature management in IP management during transfer 29-06-2021, 9:00 am View In Agenda

Akhilesh Sharma
President & Chief Medical Officer,Alkem Laboratories
Biography: Dr. Akhilesh Sharma is M.D., in Clinical Pharmacology with further training in Clinical Research and Global Pharmacovigilance at Berkley Extension, California State University, USA and Luton Medical Centre, UK and is Fellow of Royal Liverpool hospital society-U.K.. He has more than 25 years of worldwide experience in areas of Clinical Research, Medical Affairs, Regulatory, Pharmacovigilance, Translation Medicine, Biomarkers, Clinical Pharmacology across various multinational pharmaceutical companies based at US & in India. He is currently President & Chief Medical Officer for Alkem Laboratories Ltd. He also co-founded biomarker research organization GeneXY in Philadelphia, USA jointly with Wistar institute, Pennsylvania university campus.
Session Details: Preparing global approval: How to navigate 505(b) 2 USFDA pathway in different scenarios 30-06-2021, 10:00 am View In Agenda

John Patava
Chief Operating Officer,AUM Biosciences Pte Ltd
Biography:
Session Details: Adaptive designs in clinical trials: their use in accelerating clinical development 29-06-2021, 10:00 am Adaptive designs in clinical trials: their use in accelerating clinical development 29-06-2021, 10:00 am View In Agenda

Prasad Mandrekar
Senior Manager-Global Quality & Compliance,Celltrion
Biography:
Session Details: Choosing the right IRT vendor for your company to ensure your supply chain is adequately monitored 30-06-2021, 10:30 am View In Agenda

Matthew Do
Head of APAC Operations Clinical Technologies,Almac Pharmaceutical Services
Biography: Matthew Do is currently the Head of APAC Operations within Almac’s Clinical Technologies division, which specializes in providing IRT software and services to the clinical trial sector. He has over 15 years of direct industry related experience, including IRT system design and implementation, supply chain management, trial management, and systems data integration. Matthew joined Almac in 2008 and relocated from San Francisco to Singapore in 2013 to setup and oversee the APAC operations as part of Almac’s long term strategic planning in the region. He is currently based in Tokyo, Japan.
Session Details: The benefits of incorporating a configurable IRT solution to your APAC strategy 29-06-2021, 9:30 am View In Agenda

Jeong-Hyun Ryou
Medical Director, Research & Development,Boostimmune, Inc.
Biography:
Session Details: Developing a holistic-approach to protocol development to avoid costly changes during your Phase 1 trial 30-06-2021, 9:00 am View In Agenda

Arani Chatterjee
Senior Vice President, Clinical Research,Aurobindo Pharma
Biography:
Session Details: How to Develop and Maintain an Inspection-Ready Trial Master File (TMF) 30-06-2021, 10:00 am View In Agenda

Rong chen
Chief Medical Officer,Eden Biologics

Ilwon Sun
Project Manager,GC Pharma
Biography:
Session Details: How opening clinical trials in different countries can benefit stakeholders (manufacturer, doctors and patients) 29-06-2021, 11:00 am View In Agenda

Jae-Hyun (Jay) Park
Director,Genencell Co., Ltd.
Biography: Jae-Hyun (Jay) Park is a new drug developer, Ph.D., and a Korean pharmacist. He has experience in research institutes and strategic planning teams of large Korean pharmaceutical companies and start-ups. Jay has expertise in various fields such as non-clinical research, patents, and technology licensing. Currently, he is developing a new drug to treat COVID19 using natural substances.
Session Details: Experience of COVID19 clinical trials in India 29-06-2021, 12:15 pm View In Agenda

Kumar Gaurav
Director & Cluster Head, Medical Affairs,Dr. Reddy's Laboratories
Biography: Dr. Kumar Gaurav is presently working as Director & Cluster Head, Medical Affairs in Dr Reddys Lab ,Hyderabad Kumar has 12+ years of Medical affairs experience including clinical experience across diversified sectors in Pharma Industry, health care and devices.In his previous roles,Kumar was with Allergan wherein he was Head-Medical Affairs, South Asia and Global Lead for Movement Disorders. Prior to Allergen he has worked with Baxter, Astra Zeneca and Ranbaxy in Medical Affairs & Clinical Research. He has a hands on experience in managing teams and handled therapy areas including Urology, Neurosciences, Devices, Anaesthesia, Critical care, Cardio-vascular, Metabolic & Anti-infectives. In his career of over 12+ years in pharma industry,Kumar was responsible for developing & executing Medical strategy,including flagship medical education programs, digital initiatives, consensus statements, global advisory board meetings for LCM and global evidence generation projects including optimal support in investigator initiated studies with a focus on treatment paradigms, and strategies for overcoming barriers to access and optimization of patient outcomes. Kumar has been significantly involved in building thought leader (TL) advocacy across organizations in India and Global regions and also in developing processes for facilitating the same. He has been involved in launch excellence with numerous successful launches to his credit in Cardiovascular and Neurology space-Crestor,Seloken XL,Plasmalyte ,Indications expansion of Botox therapuetics etc.He is also credited with successfully establishing & driving the Field Based Medical Affairs (MSL) Excellence in all organisations he worked with. As a part of his responsibility as a Clinical Research Team Lead, he was responsible for preparing clinical development plans for various NCEs – study designs and study conduct plans especially early phase studies and atypical generics. Overseeing the preparation and timely, quality delivery of Clinical Study Protocols, Clinical Study Reports for BE studies as well as phase I to IV clinical trials, for multi centric global clinical trials across various therapeutic areas, preparation of Clinical Overviews, Feasibility reports, Safety reports, PSURs. Faced International Regulatory Audits from various regions as ANVISA, USFDA, .DCGI and providing medical support for regulatory activities. An experienced medical writer, Kumar has over 20+ publications to his credit in various National & International Journals of repute including a book Chapter Kumar has done his MBBS from MGR University Chennai and his MD in Pharmacology & Therapeutics from Banaras Hindu University, Varanasi.
Session Details: How clinical research can meet clinical practice through the use of Real World Evidence/Data (RWE/RWD) in clinical trials 29-06-2021, 2:15 pm View In Agenda

Vaibhav Choudhary
Joint Director- Medical and Clinical Affairs,Fresenius Kabi Oncology
Biography:
- A Clinical and Scientific Affairs professional with more than 14 years of experience in field of clinical trials and drug development and worked in various capacities .
- Started his career with well established global CRO in clinical QA field and later moved to sponsor end. Being on the both side (CRO and Sponsor), Vaibhav is well versed with Challenges on both side of fence.
- Currently, working with Fresenius Kabi Oncology as Joint director in Clinical and Medical Affairs function and based out of India. Managing the overall projects right from preclinical, clinical trial to regulatory registration phase. Handled various complex and multimillion dollar projects and successfully registered the various kind of products globally.
- Actively involved in CRO evaluation, selection and cross functional due diligence team for potential in-licensing opportunities .
Session Details: Clinical Outsourcing- New Trends in New Normal 30-06-2021, 10:30 am PANEL DISCUSSION: Debating how COVID-19 will impact the way we outsource and conduct clinical trials in the future: How long will we feel the ripples of this pandemic? 30-06-2021, 11:00 am PANEL DISCUSSION: Debating how COVID-19 will impact the way we outsource and conduct clinical trials in the future: How long will we feel the ripples of this pandemic? 30-06-2021, 11:00 am View In Agenda

Donna Fraser
Director Client Operations ,Novotech
Biography:
Session Details: Accelerating Clinical Trials in China and the Asia-Pacific 29-06-2021, 9:30 am View In Agenda

Moon Hwan Kim
Chief Technical Officer,BiSiChem Korea
Biography:
Session Details: PANEL DISCUSSION: Debating how COVID-19 will impact the way we outsource and conduct clinical trials in the future: How long will we feel the ripples of this pandemic? 30-06-2021, 11:00 am PANEL DISCUSSION: Debating how COVID-19 will impact the way we outsource and conduct clinical trials in the future: How long will we feel the ripples of this pandemic? 30-06-2021, 11:00 am View In Agenda

SeungHyun Hong
Deputy General Manager - clinical supply,GC Pharma
Biography:
Session Details: New GCP and the regulation about the good manufacturing practice for study medication 30-06-2021, 9:00 am View In Agenda

Prasun J Mishra
Founder CEO,Agility Pharmaceuticals
Biography: Dr. Mishra (Ex-Genentech, Ex-NCI, Ex-NIH) is the Founder and CEO of Agility Pharmaceuticals. He is a serial entrepreneur who founded his first company after graduating high school, and second company during his PhD. Since then, he has accumulated a wealth of experienced by building, investing and advising numerous other companies. He is an investor/ co-founder/ board member of a few US based corporations focused on accelerating drug discovery & development, blockchain & digital health. Dr. Mishra is also founding president & CEO of American Association for Precision Medicine (AAPM) and is leading research efforts focused on preventing & curing chronic diseases; not only treating the sick but also providing knowledge/tools to individuals to live longer, healthier lives. Widely recognized as a thought leader in the field of Technology and Healthcare, Dr. Mishra has keynoted, chaired, curated and organized numerous successful international conferences. Prior to Agility Pharma, Dr. Mishra served as a scientist and Principal Investigator at Genentech, Roche. Moreover, his passion for drug development and precision medicine has led to identification of new drug targets, biomarkers, companion diagnostics and several drugs/ combinations in the clinic. His research work has been recognized globally by over 40 prestigious awards and honors. Due to his unique perspective & selfless service, he is highly respected & sought-after mentor to many. The companies that he has advised have raised multimillion dollars. Notably, he serves as a mentor and advisor to startup accelerators such as IndieBio, Health2.0’s Project Zygote and CLSI FAST program, to help grow California’s life sciences innovation ecosystem.
Session Details: Convergence of Big Data and Artificial Intelligence in Augmenting Drug Discovery, Development and Supply Chain Management 29-06-2021, 2:15 pm View In Agenda

Frank Leu
CEO, Novapeutics,
Biography: Frank Leu is a Co-Founder and CEO of Novapeutics at Philadelphia, PA - a biopharma spun-out from the University of Pennsylvania, developing a first-in-class small molecule beta-cell restoration curative for type 2 diabetes. Prior, Frank was at a specialty pharma Verto Institute, developing biologic therapeutics for treating the neuroendocrine cancer. Frank graduated with a Pharmacology Ph.D. from Weill Cornell Graduate School of Medical Sciences in 2001, and then post-doc in a Howard Hughes Medical Institute laboratory at the Rockefeller University in molecular enzymology. He has served as an adjunct instructor at the Rutgers Cancer Institute of NJ, and is an adjunct professor at the pharmacology department of the Thomas Jefferson Medical University. Frank also founded BioPharMatrix developing blockchain solutions to lifescience innovations at all phases, and serves as advisor to the Pennovations center working with 1776 / Benjamins Desk. Frank is a thought leader in the blockchain architecture innovations in the life-sciences and drug development, Frank serves on multiple advisory boards and frequently served as chairman,
Session Details: Blockchain - Exploring the Implications for the future in drug development 29-06-2021, 11:00 am View In Agenda

Alex Ho
,Zuelling
Biography:
Session Details: Emerging trends in clinical supply, cold chain development and repackaging specialty solutions 30-06-2021, 9:30 am View In Agenda

Leonora Lim
VP Life Sciences & Healthcare Sector, Asia Pacific,DHL Customer Solutions & Innovation
Biography: Leonora has over 20 years of logistics experience in servicing specifically the Life Sciences and Healthcare sector, with over a decade spent in DHL. In her current role, she works very closely across all of the DHL business divisions. Collaborating together with these colleagues, she helps to identify, explore and meet customer needs, develop new solutions, and ultimately drive business growth in the sector across Asia Pacific. Additionally, she promotes DHL capabilities in the Life Sciences and Healthcare sector through global conferences and at DHL’s annual schedule of customer-centric events across Asia Pacific and in Singapore. Born and raised in Singapore, Leonora holds an Executive Masters in Business Administration from the Singapore Management University
Session Details: PANEL DISCUSSION: Debating how COVID-19 will impact the way we outsource and conduct clinical trials in the future: How long will we feel the ripples of this pandemic? 30-06-2021, 11:00 am PANEL DISCUSSION: Debating how COVID-19 will impact the way we outsource and conduct clinical trials in the future: How long will we feel the ripples of this pandemic? 30-06-2021, 11:00 am View In Agenda

Shichun Zhang
,Novotech

Wilman Low
Director, Life Sciences and Healthcare,DHL Supply Chain Asia Pacific
Biography: For over 10 years, I’ve been specialized in healthcare logistics, focused in areas such as clinical trial, pharmaceutical and medical technology. Currently, I head up the strategic development for the life science and healthcare sector across the Asia Pacific region in DHL Supply Chain. I work with global healthcare partners to support their transport and warehousing needs, turning their supply chain into competitive advantage.
Session Details: Shifting Gears - Accelerating APAC Clinical Trial Logistics in 2021 & Beyond 29-06-2021, 12:45 pm View In Agenda




Catalent solves today’s clinical trial challenges and develop innovative solutions for the future. Catalent’s commitment to quality and service excellence is evident in its flexible solutions, modern global facilities, and over 25 years’ experience reliably supplying thousands of studies of all sizes and complexities around the world.




Advanced Clinical is a global clinical research services organization, providing CRO, FSP, Strategic Resourcing and Consulting Services for biopharmaceutical and medical device organizations. Our company is committed to improving all lives touched by clinical research and we address the hopes of patients and healthcare professionals with industry-leading services and technology in life sciences. Visit our website to learn more about how we deliver a Better Clinical Experience.





WorldCare Clinical
Sponsorship opportunities
To enquire about sponsorship opportunities for the conference, please contact:
Nick McCudden
T: +61 280 978 126
E: NicholasMcCudden@arena-international.com
Speaker opportunities
The Outsourcing in Clinical Trials East Asia programme is written in collaboration with industry, if you would have a case study, idea or just a comment, please contact:
Chloe Roberts
Portfolio Director
T: +44 (0) 207 936 6822
E: chloe.roberts@arena-international.com